Dr. Lal PathLabs to Consider Interim Dividend for FY 2026-27 at Upcoming Board Meeting
Dr. Lal PathLabs has announced that its Board of Directors will meet on July 24, 2026, to deliberate on key financial matters including the company's performance and dividend distributions.During the scheduled meeting, the board is expected to review and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. In addition to the quarterly financial review, the board will consider a potential interim dividend on the equity shares of the company for the Financial Year 2026-27.
The discussion regarding the interim dividend follows an earlier communication from the company concerning the agenda for the July 24 meeting. The decision on the dividend remains subject to the board's consideration during the proceedings.
DALBHARAT Stock Price Movement
Shares of Dalmia Bharat Limited are slipping by 1.12% to ₹1,809.8 as of 1:20 PM today. The stock is trading with a volume of 158,594 shares as it finds support near the day's low of ₹1,798.6.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.